You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
量子生物(300149.SZ)孫公司擬承租尚華科創實驗動物中心第3層及綜合樓第4層
格隆匯 01-23 17:56

格隆匯1月23日丨量子生物(300149.SZ)公佈,為拓展大分子CDMO業務,公司全資孫公司睿智醫藥江蘇有限公司(“睿智江蘇”)擬與尚華科創投資管理(江蘇)有限公司(“尚華科創”)簽訂房屋租賃合同,睿智江蘇將承租尚華科創位於江蘇省啟東市高新區東振海路1號實驗動物中心第3層、綜合樓第4層,作為創新生物藥一站式研發生產服務平台生產經營場所使用,共租用建築面積為6743.46平方米。

自2020年2月1日至2020年12月31日,該房屋每日每平方米建築面積租金為(人民幣)1.20元。月租金總計為(人民幣)24.61萬元。

該房屋租金自2021年1月1日起,尚華科創可根據市場行情每兩年對租金進行調整,並與睿智江蘇對調整後的租金簽訂補充協議。尚華科創每次調整租金的幅度不得超過15%。

房屋租賃是為了進一步完善公司創新生物藥一站式研發生產服務平台項目,其中實驗動物中心可以進一步滿足上海睿智及睿智江蘇自身動物實驗需求,綜合樓進一步滿足公司經營發展的辦公需要。此次在關聯方的成熟項目上租賃房產可有效加快大分子CDMO產能建設,提高公司盈利能力。

此次擬簽署的租賃合同,主要是為了支持公司快速在江蘇啟東完成大分子CDMO業務產能擴建的佈局,進一步完善創新生物藥一站式研發生產服務平台。在關聯方的成熟項目上租賃房產可有效加快大分子CDMO生產線的建設,突破現有產能瓶頸,推動業績持續增長。租賃期限近19年,有利於保障公司重要生產經營場所的穩定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account